1Grothey A, Voigt W, Schober C ,et al. The role of insulin - like growth factor 1 and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors [J]. J Caneer Res Clin Oncol, 1999, 125:116 - 173.
2Navarro M, Baserga R. Limited redundancy of survival signals from type 1 insulin -like growth factor receptor[J]. Endocrinology,2001, 142(3) :1073 - 1081.
3Surmacz E. Growth factor receptors as therapeutic targets:strategies to inhibit the insulin -like growth factor 1 receptor[ J]. Oncogene, 2003,22:6589 - 6597.
4Leroith D, Roberts CT. The insulin - like growth factor system and cancer[ J]. Cancer Lett,2003, 195 : 127 - 137.
5Jerome L, Shiry L, Leyland - Jones B. Anti - insulin - like growth factor strategies in breast cancer [J]. Semin Oncol,2004,31 (1Suppl 3) :54 -63.
7Piestrzeniewicz - UlanskaD, Brys M, Semczuk A, et al. TGF - beta signaling is disrupted in endometrial - type endometrial cancinomas [J]. Gynecol Oncol,2004,95( 1 ) :173 - 180.
8Qin H, Sun Y, Benveniste EN, et al. The transcription factors SP1, SP3,and AP-2 are required for constitutive matrix metalloproteinase - 2 gene expression in astroglioma cells[ J ]. J Biol Chem, 1999,274 (41) :29130 -29137.
9Gimita L,Gimita A,Larsson O,et al. Mdm2 -dependent ubiquitination and degradation of the insulin -like growth factors 1 receptor[J]. Proc Natl Acad Sci USA, 2003,100 ( 14 ) : 8247 - 8252.
10Baserga R. Insulin - like growth factor 1 receptor signalling in prosrate cancer cells [J]. Growth Horm IGF Res, 2000,10 Suppl A:S43.
